Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Félix Jaminion"'
Autor:
Simon Buatois, Khaled Benkali, Andrea Henrich, Félix Jaminion, Yuchen Zhang, Alexandre Sostelly
Publikováno v:
Blood. 140:2918-2920
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1aede7e0ec5c61818b9f472a86afcf52
https://doi.org/10.1182/blood-2022-158244
https://doi.org/10.1182/blood-2022-158244
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 3, Pp 396-409 (2024)
Abstract Glofitamab is a novel T cell bispecific antibody developed for treatment of relapsed‐refractory diffuse large B cell lymphoma and other non‐Hodgkin's lymphoma indications. By simultaneously binding human CD20‐expressing tumor cells and
Externí odkaz:
https://doaj.org/article/7f592a5758c04aa3a48cc531488fe90e
Autor:
Joy C. Hsu, Felix Jaminion, Elena Guerini, Bogdana Balas, Walter Bordogna, Peter N. Morcos, Nicolas Frey
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 11, Pp 1357-1370 (2021)
Abstract Alectinib is an anaplastic lymphoma kinase (ALK) inhibitor approved for treatment of ALK‐positive non‐small cell lung cancer. Population pharmacokinetic (PK) models were developed for alectinib and its major active metabolite M4 using ph
Externí odkaz:
https://doaj.org/article/3042761aeaaf42898d02ef39ffc33fc7